Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 6, 2023 8:57 AM 2 min read

Analyst Highlights Asset-Backed Cannabis Loans In Chicago Atlantic's REFI With Overweight Rating

by Nicolás Jose Rodriguez Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Zuanic & Associates (Z&A) recently initiated coverage of Chicago Atlantic Real Estate Finance Inc. (NASDAQ:REFI) with an Overweight rating.  Chicago Atlantic is an externally managed commercial mortgage real estate investment trust.

"REFI is among the few active and sizeable publicly traded capital providers to the growing cannabis industry, benefitting from a supply-demand imbalance of capital that allows for YTM rates in the high teens, in the case of mortgage REITs," reads Z&A's latest report. 

REFI's Position In The Cannabis Industry

REFI is distinguished in the cannabis market as one of the few major publicly traded capital providers. Its unique position is a result of a capital supply-demand imbalance, enabling it to offer high Yield-to-Maturity (YTM) rates.

The sector currently suffers from limited banking access due to its federal legal status, despite recreational sales legalization in 24 states.

Competitive Advantage And Financial Health

REFI's competitive edge is marked by its strategy of offering shorter loan durations and lower loan-to-value ratios. The company's proficiency in leading loan syndication deals, keeping half of the origination fees, further enhances its market stance.

The report highlights REFI boasts a modest debt leverage of 23% and has access to an additional $37 million through a revolving credit facility. Its dividend is robustly covered (122%) and yields more than 12%.

According to Pablo Zuanic, senior analyst at Z&A, REFI stands out over its direct competitor AFC Gamma Inc. (NASDAQ:AFCG), thanks to its consistent performance and solid financials.

Furthermore, REFI is well-positioned to bounce back from a recent loan issue by selling the associated asset at a value exceeding its book price.

Future Prospects And Growth Potential

  • Looking ahead, REFI is projected to grow its loan book by 10% annually.
  • This growth, combined with a dividend yield above 12% and a favorable future outlook for REITs, particularly with potential interest rate reductions by the Federal Reserve in mid-2024, underpins Zuanic & Associates' positive stance on REFI.

Photo: AI-Generated Image. 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisLarge CapNewsREITInitiationManagementMarketsAnalyst RatingsTrading IdeasReal EstatePablo Zuanic
REFI Logo
REFIChicago Atlantic Real Estate Finance Inc
$12.110.17%
Overview
AFCG Logo
AFCGAdvanced Flower Capital Inc
$2.63-%
  • With the ability to fund a $350 million loan book and a history of closing $2 billion in loans, including syndications, REFI is well-equipped for growth in the burgeoning cannabis sector.
  • REFI's core business involves providing senior loans to state-licensed cannabis industry operators, with collateral including real estate, equipment receivables, and other assets.
  • The trust is managed by Chicago Atlantic REIT Manager LLC, a subsidiary of Chicago Atlantic Group LP, responsible for management fees and incentive compensation.

Z&A anticipates legal cannabis sales to reach $40 billion by 2027, growing at a nearly 10% CAGR. They also foresee gradual federal reform, including potential rescheduling of cannabis, which could significantly improve industry economics and expand REFI's investment opportunities.

REFI Logo
REFIChicago Atlantic Real Estate Finance Inc
$12.110.17%
Overview
AFCG Logo
AFCGAdvanced Flower Capital Inc
$2.63-%
Comments
Loading...